Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy

Published:2018-04-11 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Mortensen Anja¹,Spiegelberg Diana¹,Haylock Anna-Karin²,Lundqvist Hans¹,Nestor Marika¹

Affiliation:

1. Department of Immunology, Genetics and Pathology, Uppsala University, SE-75185 Uppsala, Sweden

2. Unit of Otolaryngology and Head and Neck Surgery, Department of Surgical Sciences, Uppsala University, SE-75185 Uppsala, Sweden

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas;Heliyon;2023-12

2. Xeroderma Pigmentosum: Gene Variants and Splice Variants;Genes;2021-07-29

3. 89Zr anti-CD44 immuno-PET monitors CD44 expression on splenic myeloid cells and HT29 colon cancer cells;Scientific Reports;2021-02-16

4. Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2;EJNMMI Research;2020-04-16

5. Immune-Based Approaches for the Treatment of Pediatric Malignancies;Annual Review of Cancer Biology;2020-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP